EU MedTech Innovation Pressure: What the EU Data Reveal

MedTech Leading Voice | Issue 146

This week’s update highlights published EU data quantifying sustained pressure on MedTech innovation, alongside the MHRA’s call for evidence on AI regulation and other regulatory developments shaping 2026.

📝 From the Editor

A recent post by Mario Gabrielli Cossellu underscores the ongoing pressure on MedTech innovation in Europe. This week’s featured post highlights data points that quantify alarming portfolio reductions, cancelled launches, and production exits — alongside other regulatory signals shaping 2026.

🎯 Featured Post

European MedTech Under Pressure: Evidence from the EY–DG SANTE Study

A European Commission–commissioned study by EY for DG SANTE (Directorate-General for Health and Food Safety) and published by the Publications Office of the European Union (2025) includes quantified signals that provide hard numbers on the ongoing EU innovation squeeze. The report notes the manuscript was completed in June 2025—and the findings are worth pulling forward now.

🔥 According to the study:

• 57% of economic operators reduced their EU device portfolios
• 17% ceased EU production
• 27% cancelled new device introductions
• 60% do not believe the current framework supports innovation

These figures point to sustained, structural pressure on MedTech innovation in Europe, with real downstream consequences for market access and patient availability.

Thanks to Mario Gabrielli Cossellu for surfacing the report and calling attention to the data inside it.

📌 This Week’s Top Posts (In no special order)

• Jose Bohorquez shared a practical encryption guide for securing medical device software.
• The MHRA’s call for evidence guiding AI regulation in healthcare was announced by the Medicines and Healthcare products Regulatory Agency.
• Matthew Wictome highlighted “The Compliance Trap,” a guide to transforming quality systems to build real insight and resilience.
• A proposed EU regulation to streamline medical device and in vitro diagnostic rules was summarized by Erik Vollebregt.
• In her weekly Monday news, Marina Daineko underscored three medtech updates spanning PMS expectations, AI diagnostics scale-up, and a live toxicology Q&A.
• EU MDR Compliance broke down helpful tools and methods for building a strong quality culture.
• Key changes in the FDA’s updated Clinical Decision Support guidance were detailed by J. David Giese, comparing 2022 vs. 2026 interpretations.
• Raymond W. Cohen underscored the FDA’s move to limit regulation of low-risk wellness wearables.
• The life-saving impact of vaccines, shown through once-common childhood causes of death, was revealed by Kay Judge.
• Mario Gabrielli Cossellu overviewed a 2025 EU report examining regulatory governance and innovation in medical devices and in vitro diagnostics.
• Consolidated working documents integrating the Commission’s proposed MDR/IVDR changes were posted by Richard Houlihan.
• ISOTC121 noted standards and new editions approved since January 2025 across sleep apnea, oxygen systems, and respiratory equipment.
• The final risk classification for 77 oncology medical devices under MDR 2017 was underlined by CliniExperts Services. 
• Martin King recapped the EMA’s COMBO report and its key objectives for combination products.

🗓️ Upcoming Events & Webinars

Wednesday, January 14, 2026 | 10:00 AM ET / 4:00 PM CET — MedTechUX: Conquering the Human, featuring Merrill Zavod, PhD, Associate Director of User Experience at ClariMed, Inc., exploring how human-centered design, behavioral insight, and usability strategy influence real-world device adoption, safety, and regulatory outcomes across the product lifecycle. Register with one click >>

Friday In-Focus, January 16, 2026 | 11:00 AM ET — 2026 Cybersecurity Priorities for MedTech, featuring Jose Bohorquez(CyberMed), focusing on practical cybersecurity expectations for medical devices in 2026, including encryption fundamentals, FDA security objectives, risk management alignment, and how teams can prepare for increasing regulatory scrutiny around software, connectivity, and post-market security. Registration coming soon >>

Thursday, January 22, 2026 | 10:00 AM ET / 4:00 PM CET —2026 Regulatory Roadmap: Key MDR & IVDR Compliance Prioritieswith Subject Matter Experts: Dr. Bassil Akra (AKRA Team), Erik Vollebregt (Axon Lawyers), Tom Patten (GMED) — A focused session on the milestones, pressures, and operational expectations shaping MDR and IVDR in 2026, including certificate renewal, PRRC oversight, clinical evidence pathways, and notified body interpretation trends. Register with one click >>

Wednesday, January 28, 2026 | 10:00 AM ET / 4:00 PM CET — Real-Life PMCF: Practical Lessons and 2026 Priorities, featuring subject matter experts Daniela Karrer and Matteo Mosso (Donawa Lifescience), with Diane Legere(DNV), focusing on how PMCF is applied in practice under MDR, including framing PMCF questions, selecting proportionate methods, and linking PMCF activities to CER updates and PSUR cycles, with reflections on current MDR revision work and notified body expectations. Register Now >>

🔥 February 2–4, 2026 | Carlsbad, CA — Navigating Compliance for Medical Devices — Nemko & Eisner Safety Consultants - Three days of practical training on IEC 60601, EMC/RF, usability, software lifecycle, FDA/MDR expectations, and hands-on compliance. Discount code ESC for 15% off. Learn more >>

💥 Weekly 510(k) Roundup

January 5, 2026 | From Marcus Engineering, LLC

25 total clearances across multiple categories, including 5 first-time clearances (🚀)

• Abyrx, Inc. – MONTAGE XT Cranial Cement (🚀): A moldable cranial cement designed for neurosurgical applications, enabling surgeons to control bleeding, fill cranial defects, and achieve bone-like hardening with gradual absorption during healing.
• ARC Trauma, LLC – Laryngoscope Junctional-Arterial Restriction Clamp (🚀): A trauma device designed to rapidly control life-threatening bleeding from major neck vessels while preserving airway access and cerebral blood flow in emergency settings.
• Truvian Health – Lipids Test on TruVerus® Platform: A benchtop diagnostic test delivering lab-quality lipid results from small blood samples at the point of care, supporting faster and more accessible routine testing in clinics and pharmacies.

📋 Regulatory Roundup

December 29, 2025 Issue | By Martin King

January 5, 2026 Issue | By Martin King

This week’s regulatory activity highlights early 2026 signals across medical devices, IVDs, medicines, and digital health, with global regulators reinforcing lifecycle oversight, cybersecurity expectations, and operational enforcement.

Key developments:

• Strengthened post-market and lifecycle controls across multiple jurisdictions
• Accelerated pathways for innovation and advanced technologies
• Increased focus on cybersecurity, software supply chains, and SBOM expectations
• Structural changes in global accreditation frameworks toward a single IAF/ILAC model
• Continued emphasis on risk-based oversight and practical enforcement guidance
• Growing alignment around data-driven regulation and cross-border convergence

Explore the Issue >>

🔥 Postscript

Catch all our MLV Webinar Replays and Friday In-Focus Calls on our YouTube Channels.

- Sean 🐝